I

InDex Pharmaceuticals Holding AB
STO:FLERIE

Watchlist Manager
InDex Pharmaceuticals Holding AB
STO:FLERIE
Watchlist
Price: 45 SEK 0.78%
Market Cap: 3.5B SEK
Have any thoughts about
InDex Pharmaceuticals Holding AB?
Write Note

InDex Pharmaceuticals Holding AB
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

InDex Pharmaceuticals Holding AB
Total Liabilities Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
IRLAB A
MOB

Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Total Liabilities
kr34.7m
CAGR 3-Years
31%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Total Liabilities
kr1.6B
CAGR 3-Years
85%
CAGR 5-Years
103%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Total Liabilities
kr503.7m
CAGR 3-Years
31%
CAGR 5-Years
28%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Total Liabilities
kr2.4B
CAGR 3-Years
77%
CAGR 5-Years
152%
CAGR 10-Years
N/A
IRLAB Therapeutics AB
STO:IRLAB A
Total Liabilities
kr61.4m
CAGR 3-Years
40%
CAGR 5-Years
38%
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Total Liabilities
kr24m
CAGR 3-Years
-36%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is InDex Pharmaceuticals Holding AB's Total Liabilities?
Total Liabilities
34.7m SEK

Based on the financial report for Jun 30, 2024, InDex Pharmaceuticals Holding AB's Total Liabilities amounts to 34.7m SEK.

What is InDex Pharmaceuticals Holding AB's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
9%

Over the last year, the Total Liabilities growth was -23%. The average annual Total Liabilities growth rates for InDex Pharmaceuticals Holding AB have been 31% over the past three years , 9% over the past five years .

Back to Top